NetworkNewsBreaks

MondayMar 08, 2021 1:54 pm

NetworkNewsBreaks – GT Biopharma Inc. (NASDAQ: GTBP) Releases Preclinical Results for Prostate Cancer Treatment

GT Biopharma (NASDAQ: GTBP), a clinical-stage biopharmaceutical company focused on disruptive, target-directed natural killer (“NK”) cell engager immunotherapy technologies, has announced preclinical results for its ROR1 (“ROR1”) TriKE(TM) (“TriKE”) product candidate, which is being evaluated as a prospective therapy for the treatment of prostate cancer. The treatment is based on the fact that tyrosine kinase transmembrane receptor ROR1 has been shown to be overexpressed on certain cancer cells and to play a functional role in influencing the metastatic potential of various solid tumor cancers. Through its TriKE treatment, GT Biopharma targets ROR1 on cancer cells, redirecting NK cells to attack…

Continue Reading

MondayMar 08, 2021 1:47 pm

NetworkNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Develops First-Ever Effective Treatment for Root-Rot Disease

MustGrow (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide is 100% effective against root-rot disease. This announcement followed a recent round of laboratory tests, “which were conducted by an independent third-party lab,” an article on MustGrow’s novel accomplishment details. MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, becomes the first to develop an effective treatment for this disease. The “patented mustard-derived biopesticide achieved 100% control over Aphanomyces euteiches zoospores (Aphanomyces) within 24 hours and at economic application rates… Aphanomyces is a soil-borne, root-rot disease…

Continue Reading

MondayMar 08, 2021 1:33 pm

NetworkNewsBreaks – Why Mohawk Group Holdings Inc. (NASDAQ: MWK) Is ‘One to Watch’

Mohawk Group Holdings (NASDAQ: MWK) is a leading tech-enabled consumer products platform that utilizes machine learning, natural language processing and data analytics to design, develop, market, and sell products. Mohawk’s proprietary AIMEE(R) platform leverages data and artificial intelligence (“AI”) to automate the design, development and launch of best-selling consumer products. The company owns and operates 12 brands to sell consumer products across multiple categories ranging from kitchenware and home appliances to environmental appliances, beauty offerings and even consumer electronics. A recent article discussing the company reads, “AIMEE(R) (AI Mohawk E-commerce Engine) is Mohawk’s proprietary platform that leverages data and AI…

Continue Reading

MondayMar 08, 2021 1:25 pm

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Opens First-Ever Pneusomnia Clinic, Unveils New Tech to Test for Sleep Apnea at Home

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), has opened the first Pneusomnia clinic, a clinician-owned, integrated medical-dental sleep center. The center will feature the Vivos System through its Medical Integration Division. Located in Del Mar, California, the clinic is owned and operated by local physicians, including Dr. Mimi Guarneri, a cardiologist, founder and president of the Academy of Integrative Health and Medicine; she will lead the center. Vivos created its Medical Integration Division last year with the objective of fostering an environment where medical…

Continue Reading

MondayMar 08, 2021 12:54 pm

NetworkNewsBreaks – Asia Broadband Inc. (AABB) Engages InvestorBrandNetwork for Corporate Communications Expertise

Asia Broadband (OTC: AABB), a resource company focused on the production, supply and sale of precious and base metals, today announced that it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Asia Broadband leverages a vertically integrated approach to sales transactions, utilizing its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client networks in Asia. As part of the Asia Broadband and IBN relationship, IBN will leverage…

Continue Reading

MondayMar 08, 2021 12:30 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Showcases Virtual Event Platform Capabilities at Prestigious B. Riley Vision Day

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently served as the exclusive technology host for B. Riley Securities’ 2021 Vision Day. The prestigious event was held on the Sequire Virtual Events platform, which allowed the Sequire community privileged access to sessions and content. The daylong virtual investor conference featured video presentations and fireside chats discussing top stock picks from B. Riley’s award-winning equity research team. “We were honored to have been selected by B. Riley Securities to host its 2021 Vision Day event following our…

Continue Reading

MondayMar 08, 2021 12:24 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Development of Newly Designed System for Direct-to-Drain Fluid Waste Management

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its Skyline Medical Division is renewing the development of a new Generation 3 STREAMWAY(R) System for direct-to-drain fluid waste management. According to the update the new device will see no change to its intended use and will not require a separate 501(k) submission with the Food and Drug Administration. In addition, the new design will include key changes to the product that will be smaller, lighter and easier to install with the goal of improving operator reliability, reducing…

Continue Reading

MondayMar 08, 2021 11:47 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Reports Continued Month-over-Month Growth

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), a comprehensive e-commerce solution allowing drivers and automotive dealers to buy, sell, trade, lease and finance vehicles from any digital device, has released its February 2021 financial numbers, noting that the company’s strong month-over-month growth has continued into 2021. In the announcement, PowerBand reported that its February's gross sales totaled C$8 million, which is a 19.4% or C$1.3 million increase over its January 2021 numbers of C$6.7 million. This is particularly noteworthy because February is a short month, which included a major cold-weather incident that negatively impacted the economy in much of the…

Continue Reading

MondayMar 08, 2021 11:41 am

NetworkNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Appoints Former Shell Oil Exec to PowerTap Board

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, announced that it has appointed David Bray, a former general manager and corporate officer for Shell Oil Products US, to the advisory board of PowerTap Hydrogen Fueling Company, an investee company. In his new role, Bray will provide insight and expertise in critical product development and services related to accelerating the development of PowerTap’s proprietary modular 1,250 kg hydrogen production and dispensing unit. Bray has more than three decades of experience in the business and strategy development and fuels and marketing sectors. While at Shell, he served as…

Continue Reading

MondayMar 08, 2021 11:16 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Plans to Participate in 33rd Annual ROTH Conference, $10M Registered Direct Offering

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that its CEO and Chairman, James Sapirstein, will participate in a panel discussion during the ROTH Conference slated to be held virtually from March 15-17, 2021. According to the update, the panel, “Therapeutics Against SARS-CoV-2 – Viral Variants Will Not Fade Away: A discussion of various developmental therapeutics for SARS-CoV-2 infection,” is scheduled to begin at 12:00 p.m. ET on March 15, 2021. During the panel, Sapirstein will discuss the need for drug therapies to address issues related to COVID-19, including…

Continue Reading